About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Amiselimod (Amiselimod)

[1] Amiselimod (Amiselimod) 💬

[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬

Name	Full Name
S1PR1	sphingosine 1-phosphate receptor 1
S1PR2	sphingosine 1-phosphate receptor 2
S1PR3	sphingosine 1-phosphate receptor 3
S1PR4	sphingosine 1-phosphate receptor 4 precursor
S1PR5	sphingosine 1-phosphate receptor 5

[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬

[1] 97 💬

2

AmiselimodProduct Code: MT-1303Pharmaceutical Form: CapsuleINN or Proposed INN: amiselimodOther descriptive name: MT-1303Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 0.2-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral useProduct Name: AmiselimodProduct Code: MT-1303Pharmaceutical Form: CapsuleINN or Proposed INN: amiselimodOther descriptive name: MT-1303Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 0.4-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use

-

-

-

-

[1] 97 💬